Addressing tuberculosis in the context of malnutrition and HIV coinfection

Food and Nutrition Bulletin

Volumn 31, Issue 4, 2010, Pages

  Semba, Richard D ^a   Darnton Hill, Ian ^b   De Pee, Saskia ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c World Food Programme   (Italy)

Author keywords

Food insecurity; HIV AIDS; Latent tuberculosis infection; Malnutrition; Tuberculosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE TRANSMISSION; FOOD SECURITY; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; MALNUTRITION; MEDICAL GEOGRAPHY; RISK FACTOR; TUBERCULOSIS;

SOUTH ASIA; SOUTHEAST ASIA; SUB-SAHARAN AFRICA;

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; CATERING SERVICE; COINFECTION; COMPLICATION; DIET; DIET THERAPY; HEALTH CARE POLICY; HIV INFECTIONS; HUMAN; MALNUTRITION; RECURRENT DISEASE; RISK FACTOR; TUBERCULOSIS; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; COINFECTION; DIET; FOOD SUPPLY; HIV INFECTIONS; HUMANS; MALNUTRITION; NUTRITION POLICY; NUTRITION THERAPY; RECURRENCE; RISK FACTORS; TUBERCULOSIS; WEIGHT GAIN; WEIGHT LOSS;

EID: 78751658822     PISSN: 03795721     EISSN: None     Source Type: Journal    
DOI: 10.1177/15648265100314s404     Document Type: Article

References (151)

1. O'Reilly LM, Daborn CJ. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tubercle Lung Dis 1995; 76(suppl): 1-46.
2. Young DB, Gideon H, Wilkinson RJ. Eliminating latent tuberculosis. Trends Microbiol 2009; 17: 183-8.
3. McShane H. Co-infection with HIV and TB: double trouble. Int J STD AIDS 2005; 7: 962-7.
4. Pelly TF, Santillan CF, Gilman RH, Cabrera LZ, Garcia E, Vidal C, Zimic MJ, Moore DA, Evans CA. Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis 2005; 9: 977-84.
5. Comas I, Gagneux S. The past and future of tuberculosis research. PLoS Pathogens. Published 26 Oct 2009. Available at: http://www.ncbi.nlm.nih.gov/pmc/ artides/ PMC2745564/. Accessed 22 September 2010.
6. World Health Organization Stop TB Partnership. 2009 Update: tuberculosis facts. Available at: http://www.who. int/tb/publications/2009/tbfactsheet- 2009update-onepage.pdf. Accessed 19 August 2010.
7. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240-6.
8. Jassal M, Bishai WR. Extensively drug-resistant tuberculosis. Lancet 2009; 9: 19-30.
9. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2008 Report on the global AIDS/HIV epidemic. Geneva: UNAIDS, 2008.
10. Gauss H. Nutrition and tuberculosis. Chest 1936; 2: 20-4.
11. McKeown T. The modern rise of population. New York: Academic Press, 1976.
12. van Lettow M, Fawzi WW, Semba RD. Triple trouble: the role of malnutrition in tuberculosis and human immunodeficiency virus co-infection. Nutr Rev 2003; 61: 81-90.
13. Dannenberg AM. Chemical and enzymatic host factors in resistance to tuberculosis. In: Kubica GP, Wyane LG, eds. The mycobacteria. A sourcebook. Part B. New York and Basel, Switzerland: Marcel Dekker, 1985: 721-60.
14. Cegielski JP, McMurray DN. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 2004; 8: 296-8.
15. McMurray DN, Cegielski JP. The influence of nutrition on the risk and outcomes of tuberculosis. In: Academy of Sciences of South Africa Consensus Panel on Nutrition, HIV/AIDS, and TB. HIV/AIDS, TB, and nutrition: scientific inquiry into the nutritional influences on human immunity with special reference to HIV infection and active TB in South Africa. Pretoria: Academy of Sciences of South Africa, 2007.
16. Milburn HJ. Primary tuberculosis. Curr Opin Pulm Med 2001; 7: 133-41.
17. Eilertsen E. Epidemics of primary tuberculosis and their significance. Acta Tuberc Scand 1959; 37: 203-16.
18. Poulsen A. A tuberculosis epidemic on the Faroe Islands. Acta Tuberc Scand 1947; 21: 58-69.
19. Frostad S. Tuberculosis incipiens: a clinical roentgenological investigation of the earliest forms of the pulmonary tuberculosis, with special view to its relation to the primary infection. Acta Tuberc Scand 1944;(suppl 13): 1-316.
20. Downes J. An experiment in the control of tuberculosis among Negroes. Milbank Mem Fund Q 1950; 28: 127-59.
21. Marais BJ, Gie RP, Obihara CC, Hesseling AC, Schaaf HS, Beyers N. Well defined symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis Child 2005; 90: 1162-5.
22. Shimeles D, Lulseged S. Clinical profile and pattern of infection in Ethiopian children with severe proteinenergy malnutrition. East Afr Med J 1994; 71: 264-7.
23. Faber K. Tuberculosis and nutrition. Acta Tuberc Scand 1938; 12: 287-335.
24. Leitch I. Diet and tuberculosis. Proc Nutr Soc 1945; 3: 156-74.
25. Leyton GB. Effects of slow starvation. Lancet 1946; 2: 73-9.
26. Fine P. Leprosy and tuberculosis-an epidemiological comparison. Tubercle 1984; 65: 137-53.
27. Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 2010; 39: 149-55.
28. Getz HR, Long ER, Henderson HJ. A study of the relation of nutrition to the development of tuberculosis. Influence of ascorbic acid and vitamin A. Am Rev Tuberc 1951; 64: 381-93.
29. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
30. Rodrigues LA, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993; 22: 1154-8.
31. Ziegler HD, Ziegler PB. Depression of tuberculin reaction in mild and moderate protein-calorie malnourished children following BCG vaccination. Johns Hopkins Med J 1975; 137: 59-64.
32. Sinha DP, Bang FB. Protein and calorie malnutrition, cell-mediated immunity, and B.C.G. vaccination in children from rural West Bengal. Lancet 1976; 2: 531-4.
33. Satyanarayana K, Bhaskaram P, Seshu VC, Reddy V. Influence of nutrition on postvaccinial tuberculin sensitivity. Am J Clin Nutr 1980; 33: 2334-7.
34. Cohen MK, Bartow RA, Mintzer CL, McMurray DN. Effects of diet and genetics on Myobacterium bovis BCG vaccine efficacy in inbred guinea pigs. Infect Immun 1987; 55: 314-9.
35. Adegbola RA, Falade AG, Sam BE, Aidoo M, Baldeh I, Hazlett D, Whittle H, Greenwood BM, Mulholland EK. The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J 1994; 13: 975-82.
36. Ikeogu MO, Wolf B, Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 1997; 76: 124-8.
37. Chintu C, Mudenda V, Lucas S, Nunn A, Lishimpi K, Maswahu D, Kasolo F, Mwaba P, Bhat G, Terunuma H, Zumla A, for the UNZA-UCLMS Project Paediatric Post-mortem Study Group. Lung diseases at necroscopy in African children dying from respiratory illnesses: a descriptive necroscopy study. Lancet 2002; 360: 985-90.
38. Shet A, Mehta S, Rajagopalan N, Dinakar C, Ramesh E, Samuel NM, Indumathi CK, Fawzi WW, Kurpad AV. Anemia and growth failure among HIV-infected children in India: a retrospective analysis. BMC Pediatr 2009; 9: 37.Available at: http://www.biomedcentral. com/1471-2431/9/37/. Accessed 22 September 2010.
39. Kumar A, Updahyay S, Kumari G. Clinical presentation, treatment outcome and survival among the HIV infected children with culture confirmed tuberculosis. Curr HIV Res 2007; 5: 499-504.
40. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr, Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326: 231-5.
41. Powell DA, Hunt WG. Tuberculosis in children. Adv Pediatr 2006; 53: 279-322.
42. Moreno S, Miralles P, Diaz MD, Baraia J, Padilla B, Berenguer J, Alberdi JC. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long term effect on the development of tuberculosis and survival. Arch Intern Med 1997; 157: 1729-34.
43. Whalen CC, Johnson JL, Okwera A, Horn DL, Huebner R, Mugyenyi P, Mugerwa RD, Ellner JJ. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 801-8.
44. Hawken MP, Meme HK, Elliott LC, Chakaya JM, Morris JS, Githui WA, Juma ES, Odhiambo JA, Thiong'o LN, Kimari JN, Ngugi EN, Bwayo JJ, Gilks CF, Plummer FA, Porter JD, Nunn PP, McAdam KP. Isoniazid preventive therapy for tuberculosis in HI V-1 -infected adults: results of a randomised trial. AIDS 1997; 11: 875-82.
45. Moreno S, Baraia-Etxaburu J, Douza E. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194-8.
46. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268: 1581-7.
47. Chintu C, Ganapati B, Luo C, Ravilgione M, Diwan V Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis. Pediatr Infect Dis J 1993; 12: 499-504.
48. Sassan-Morokro M, De Cock KM, Ackah A, Vetter KM, Doorly R, Brattegaard K, Coulibaly D, Coulibaly IM, Gayle H. Tuberculosis and HIV infection in children in Abidjan, Côte d'Ivoire. Trans R Soc Trop Med Hyg 1994; 88: 178-81.
49. Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, Roux P, Godfrey-Faussett P, Schaaf HS. High incidence of tuberculosis among HIV-infected infants: evidence from a South African populationbased study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48: 108-14.
50. Harries AD, Nkhoma WA, Thompson PJ, Nyangulu DS, Wirima JJ. Nutritional status in Malawian patients with pulmonary tuberculosis and response to chemotherapy. Eur J Clin Nutr 1988; 42: 445-50.
51. van Lettow M, Harries AD, Kumwenda JJ, Zijlstra EE, Clark TD, Taha TE, Semba RD. Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect Dis 2004; 4: 61.Available at: http:// www.biomedcentral.com/1471-2334/4/61. Accessed 22 September 2010.
52. Kassu A, Yabutani T, Mahmud ZH, Mohammad A, Nguyen N, Huong BT, Hailemariam G, Dira E, Ayele B, Wondmikun Y, Motonaka J, Ota F. Alterations in serum levels of trace elements in tuberculosis and HIV infections. Eur J Clin Nutr 2006; 60: 580-6.
53. Macallan DC, McNurlan MA, Kurpad AV, de Souza G, Shetty PS, Calder AG, Griffin GE. Whole body protein metabolism in human pulmonary tuberculosis and undernutrition: evidence for anabolic block in tuberculosis. Clin Sci 1998; 94: 321-31.
54. Swaminathan S, Padmapriyadarsini C, Sukumar B, Iliayas S, Kumar SR, Triveni C, Gomathy P, Thomas B, Mathew M, Narayanan PR. Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India. Clin Infect Dis 2008; 46: 946-9.
55. Paton NI, Castello-Branco LR, Jennings G, Ortigao de Sampaio MB, Elia M, Costa S, Griffin GE. Impact of tuberculosis on the body composition of HIV-infected men in Brazil. J Acquir Immune Defic Syndr Hum Retroviral 1999; 20: 265-71.
56. Shah S, Whalen C, Kotler DP, Mayanja H, Namale A, Melikian G, Mugerwa R, Semba RD. Severity of human immunodeficiency virus infection is associated with decreased phase angle, fat mass and body cell mass in adults with pulmonary tuberculosis infection in Uganda. J Nutr 2001; 131: 2843-7.
57. van Lettow M, van der Meer JJM, West C, van Crevel R, Semba RD. Interleukin-6 and HIV load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi. J Clin Endocrinol Metab 2005; 90: 4771-6.
58. Mehta JB, Fields CL, Byrd RP, Roy TM. Nutritional status and mortality in respiratory failure caused by tuberculosis. Tennessee Med 1996; (October): 369-71.
59. Kim DK, Kim HJ, Kwon SY, Yoon HI, Lee CT, Kim YW, Chung HS, Han SK, Shim YS, Lee JH. Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J 2008; 32: 1031-6.
60. Getz HR, Koerner A. Vitamin A and ascorbic acid in pulmonary tuberculosis: determination in plasma by the photoelectric colorimeter. Am J Med Sci 1941; 202: 831-47.
61. Getz HR, Westfall IS, Henderson HJ. Nutrition in tuberculosis as evaluated by blood analysis. Am Rev Tuberc 1944; 50: 96-111.
62. Prokopiev DI. Vitamin A content and carotene in blood plasma in pulmonary tuberculosis. Ter Arkh 1966; 38: 54-9.
63. Evans DIK, Attock B. Folate deficiency in pulmonary tuberculosis: relationship to treatment and to serum vitamin A and beta-carotene. Tubercle 1971; 52: 288-94.
64. Crimm PD, Short DM. Vitamin A content of the human liver in tuberculosis. Ann Intern Med 1939; 13: 61-3.
65. Moore T, Sharman IM. Vitamin A levels in health and disease. Br J Nutr 1951; 5: 119-29.
66. Getz HR, Hildebrand GB, Finn M. Vitamin A deficiency in normal and tuberculous persons as indicated by the biophotometer. JAMA 1939; 112: 1308-11.
67. Harris R, Harter JS. Night blindness and vitamin A deficiency in pulmonary tuberculosis. South Med J 1940; 33: 1064-5.
68. Solon FS, Popkin BM, Fernandez TL, Latham MC. Vitamin A deficiency in the Philippines: a study of xerophthalmia in Cebu. Am J Clin Nutr 1978; 31: 360-8.
69. Rwangabwoba JM, Fischman H, Semba RD. Serum vitamin A levels during tuberculosis and human immunodeficiency virus infection. Int J Tuberc Lung Dis 1998; 2: 771-3.
70. Breese BB, Watkins E, McCoord AB. The absorption of vitamin A in tuberculosis. JAMA 1942; 119: 3-4.
71. Davies PDO. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tuberculosis 1985; 66: 301-4.
72. Douglas AS, Strachan DP, Maxwell JD. Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax 1996; 51: 944-6.
73. Thomasset M. Vitamine D et système immunitaire. Pathol Biol (Paris) 1994; 42: 163-72.
74. 3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 1987; 55: 2945-50.
75. 3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57: 159-63.
76. Rook GA, Taverne J, Steele J, Altes C, Stanford JL. Interferon gamma, cholecalciferol metabolites, and the regulation of anti-mycobacterial and immunopathological mechanisms in human and murine macrophages. Bull Int Union Tuberc Lung Dis 1987; 62: 41-43.
77. Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol 1991; 84: 200-6.
78. 3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages. Am Rev Respir Dis 1989; 139: 549-52.
79. McMurray DN, Bartow RA, Mintzer CL, HernandezFrontera E. Micronutrient status and immune function in tuberculosis. Ann N Y Acad Sci 1990; 587: 59-69.
80. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, Wright D, Latif M, Davidson RN. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000; 355: 618-21.
81. Friis H, Range N, Pedersen ML, Mølgaard C, Changalucha J, Krarup H, Magnussen P, Scborg C, Andersen AB. Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr 2008; 138: 2474-80.
82. Hafiez AA, Abdel-Hafez MA, Salem D, Abdou MA, Helaly AA, Aarag AH. Calcium homeostasis in untreated pulmonary tuberculosis. Kekkaku 1990; 65: 308-16.
83. Bradley GW, Sterling GM. Hypercalcaemia and hypokalaemia in tuberculosis. Thorax 1978; 33: 464-7.
84. Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 1987; 71: 341-4.
85. Fuss M, Karmali R, Pepersack T, Bergans A, Dierckx P, Prigogine T, Bergmann P, Corvilain J. Are tuberculous patients at a great risk from hypercalcemia? Q J Med 1988; 69: 868-78.
86. Grange JM, Davies PD, Brown RC, Woodhead JS, Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985; 66: 187-91.
87. Chan TY, Poon P, Pang J, Swaminathan R, Chan CH, Nisar M, Williams CS, Davies PD. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg 1994; 97: 26-30.
88. Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985; 40: 187-90.
89. Williams SE, Wardman AG, Taylor GA, Peacock M, Cooke JN. Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism. Tubercle 1985; 66: 49-54.
90. Kitrou MP, Phytou-Pallikari A, Tzannes SE, Virvidakis K, Mountokalakis TD. Serum calcium during chemotherapy for active pulmonary tuberculosis. Eur J Respir Dis 1983; 64: 347-54.
91. Brodie MJ, Boobis AR, Hillyard CJ, Abeyasekera G, MacIntyre I, Park BK. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther 1981; 30: 363-7.
92. Perry W, Erooga MA, Brown J, Stamp TC. Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis. J R Soc Med 1982; 75: 533-6.
93. Knox-Macaulay HH. Serum cobalamin concentration in tuberculosis. A study in the Guinea savanna of Nigeria. Trap Geogr Med 1990; 42: 146-50.
94. Morris CD, Bird ARD, Nell H. The haematological and biochemical changes in severe pulmonary tuberculosis. Q J Med 1989; 73: 1151-9.
95. Visser ME, Texeira-Swiegelaar C, Maartens G. The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2004; 8: 260-2.
96. Knox-Macaulay H. Folate status in tuberculosis: a study in the Guinea savanna of Nigeria. Eur J Clin Nutr 1989; 43: 411-20.
97. 12 in tuberculosis. Scand J Haematol 1967; 4: 283-91.
98. Cameron SJ, Home NW. The effect of tuberculosis and its treatment on erythropoiesis and folate activity. Tubercle 1971; 52: 37-48.
99. Bakaev W, Duntau AP. Ascorbic acid in blood serum of patients with pulmonary tuberculosis and pneumonia. Int J Tuberc Lung Dis 2004; 8: 263-6.
100. Lamsal M, Gautam N, Bhatta N, Toora BD, Bhattacharya SK, Baral N. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis. Southeast Asian J Trop Med Public Health 2007; 38: 695-703.
101. Madebo T, Lindtjørn B, Aukrust P, Berge RK. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. Am J Clin Nutr 2003; 78: 117-22.
102. Vijayamalini M, Manoharan S. Lipid peroxidation, vitamins C, E and reduced glutathione levels in patients with pulmonary tuberculosis. Cell Biochem Funct 2004; 22: 19-22.
103. Shor-Posner G, Miguez MJ, Pineda LM, Rodriguez A, Ruiz P, Castillo G, Burbano X, Lecusay R, Baum M. Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 29: 169-73.
104. van Lettow M, West C, van der Meer JJM, Wieringa F, Semba RD. Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukin-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi. Eur J Clin Nutr 2005; 59: 526-32.
105. Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 1998; 114: 1244-52.
106. Zachariah R, Spielmann MP, Harries AD, Salaniponi FM. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trap Med Hyg 2002; 96: 291-4.
107. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcantara F, Sanchez E, Sarria M, Becerra M, Smith Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P. Community-based therapy for multidrugresistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348: 119-28.
108. Paton NI, Sangeetha S, Earnest A, Bellamy R. The impact of malnutrition on survival and CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Med 2006; 7: 323-30.
109. van der Sande MA, Schim van der Loeff MF, Aveika AA, Sabally S, Togun T, Sarge-Njie R, Alabi AS, Jaye A, Corrah T, Whittle HC. Body mass index at time of HIV diagnosis: a strong and independent predictor of survival. J Acquir Immune Defic Syndr 2004; 37: 1288-94.
110. Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Line A, Makombe S, Harries AD. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006; 20: 2355-60.
111. Mugusi FM, Mehta S, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health 2009; 9: 409.Available at: http://www.biomedcentral.eom/1471-2458/9/409/. Accessed 22 September 2010.
112. Langi P, Semba RD, Mugerwa RD, Whalen CC. Vitamin A deficiency and mortality among human immunodeficiency virus-infected adults in Uganda. Nutr Res 2003; 23: 595-605.
113. Nkhoma WA, Harries AD, Reeve PA, Nyangulu DS, Wirima JJ. Nutrition in pulmonary tuberculosis: a comparison of African patients from Malawi and Nigeria. East Afr Med J 1987; 64: 643-7.
114. Kennedy N, Ramsay A, Uiso L, Gutmann J, Ngowi FI, Gillespie SH. Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Trans R Soy Trop Med Hyg 1996; 90: 162-6.
115. Onwubalili JK. Malnutrition among tuberculous patients in Harrow, England. Eur J Clin Nutr 1988; 42: 363-6.
116. Schwenk A, Hodgson L, Wright A, Ward LC, Rayner CF, Grubnic S, Griffin GE, Macallan DC. Nutrient partitioning during treatment of tuberculosis: gain in body fat mass but not in protein mass. Am J Clin Nutr 2004; 79: 1006-12.
117. Klausner JD, Makonkawykeyoon S, Akarasewi P, Nakata K, Kasinrerk W, Corral L, Dewar RL, Lane HC, Freedman VH, Kaplan G. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retroviral 1996; 11: 247-57.
118. Drain PK, Kupka R, Mugusi F, Fawzi WW. Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am J Clin Nutr 2007; 85: 333-45.
119. Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the Nutrition for Healthy Living cohort. Clin Infect Dis 2006; 42: 836-42.
120. Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, James GT, Nix DE. Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids. Pharmacotherapy 1998; 18: 1205-11.
121. Zent C, Smith P. Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide. Tuber Lung Dis 1995; 76: 109-13.
122. Peloquin CA, Berning SE, Huitt GA, Iseman MD. AIDS and TB drug absorption. Int J Tuberc Lung Dis 1999; 3: 1143-4.
123. Purohit SE, Sarkar SK, Gupta ML, Jain DK, Gupta PR, Mehta YR. Dietary constituents and rifampicin absorption. Tubercle 1987; 68: 151-2.
124. Paton NI, Chua Y-K, Earnest A, Chee CBE. Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. Am J Clin Nutr 2004; 80: 460-5.
125. Martins N, Morris P, Kelly PM. Food incentives to improve completion of tuberculosis treatment: randomized controlled trial in Dili, Timor-Leste. BMJ 2009; 339: b4248.
126. Karyadi E, West CE, Schultink W, Nelwan RHH, Gross R, Amin Z, Dolmans WMV, Schlebusch H, van der Meer JWM. A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr 2002; 75: 720-7.
127. Volosevich GV. Functional activity of blood T-lymphocytes in patients with pulmonary tuberculosis treated with chemotherapeutic drugs and vitamins. Probl Tuberk 1982; 3: 47-50.
128. Safaryan MF, Karagezyan KG, Karapetyan ET, Avanesyan NA. Efficacy of antioxidative therapy in patients with pulmonary tuberculosis and correction of lipid peroxidation. Probl Tuberk 1990; 5: 40-4.
129. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M. Vitamin D as supplementary treatment for tuberculosis: a doubleblind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-50.
130. Drabowski MP, Peel WE, Thomson AE. Plasma membrane cholesterol regulates human lymphocyte cytotoxic function. Eur J Immunol 1980; 10: 821-7.
131. Pérez-Guzmán C, Vargas MH, Quiñonez F, Bazavilvazo N, Aguilar A. A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest 2005; 127: 643-51.
132. Schön T, Elias D, Moges F, Melese E, Tessema T, Stendahl O, Britton S, Sundqvist T. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. Eur Respir J 2003; 21: 483-8.
133. Lounis N, Truffot-Pernot C, Grosset J, Gordeuk VR, Boelaert JR. Iron and Mycobacterium tuberculosis infection. J Clin Virol 2001; 20: 123-6.
134. Darnton-Hill I, Ahmed F. Micronutrients: immunological and infection effects on nutritional status and impact on health in developing countries. In: Bendich A, Deckelbaum RJ, eds. Preventive nutrition. Totowa, NJ, USA: Humana Press, 2009: 567-609.
135. Papathakis P, Piwoz E. Nutrition and tuberculosis: a review of the literature and considerations in TB control programs. USAID Africa's Health in 2010.2008. Washington, D.C.
136. Das BS, Devi U, Mohan Rao C, Srivastava VK, Rath PK, Das BS. Effect of iron supplementation on mild to moderate anaemia in pulmonary tuberculosis. Br J Nutr 2003; 90: 541-50.
137. Gangaidzo IT, Moyo VM, Mvundura E, Aggrey G, Murphree NL, Khumalo H, Saungweme T, Kasvosve I, Gomo ZA, Rouault T, Boelaert JR, Gordeuk VR. Association of pulmonary tuberculosis with increased dietary iron. J Infect Dis 2001; 184: 936-9.
138. Arbor Nutrition. TB and nutrition: what's new? Arbor Clinical Nutrition Updates 2009(Oct); 312: 1-3.
139. Martens GW, Arikan MC, Lee J, Ren F, Vallerskog T, Kornfeld H. Hypercholesterolemia impairs immunity to tuberculosis. Infect Immun 2008; 76: 3464-72.
140. Hernández-Garduňo E. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake-comments by Hernández-Garduňo. Br J Nutr 2009; 101: 145.
141. Range N, Changalucha J, Krarup H, Magnussen P, Anderssen ÅB, Friis H. The effect of multi-vitamin/ mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomized twoby-two factorial trial in Mwanza, Tanzania. Br J Nutr 2006; 95: 762-70.
142. Semba RD, Kumwenda J, Zijlstra E, Ricks MO, van Lettow M, Whalen C, Clark TD, Jorgensen L, Kohler J, Kumwenda N, Taha TE, Harries AD. Micronutrient supplements and mortality of HIV-infected adults with pulmonary TB: a controlled clinical trial. Int J Tuberc Lung Dis 2007; 11: 854-9.
143. Villamor E, Mugusi F, Urassa W, Bosch RJ, Saathoff E, Matsumoto K, Meydani SN, Fawzi WW. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J Infect Dis 2008; 197: 1499-505.
144. de Pee S, Semba RD. Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food Nutr Bull 2010; 31 (Suppl): S313-S344.
145. Abba K, Sudarsanam TD, Grobler L, Volmink J. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2008; 4: CD006086.
146. Frega R, Duffy F, Rawat R, Grede N. Food insecurity in the context of HIV/AIDS: A framework for a new era of programming. Food Nutr Bull 2010; 31(Suppl): S292-S312.
147. Panagides D, Graciano R, Atekyereza P, Gerberg L, Chopra M. Discussion paper 48: a review of nutrition and food security approaches in HIV and AIDS Programmes in Eastern and Southern Africa. Regional Network for Equity in Health in East and Southern Africa. 2007. Available at: http://www.sarpn.org.za/ documents/ d0002685/index.php. Accessed 22 September 2010.
148. Ivers LC, Cullen KA, Freeberg KA, Block S, Coates J, Webb P. HIV/AIDS, undernutrition, and food security. Clin Inf Dis 2009; 49: 1061-8.
149. Brinkman H-J, de Pee S, Sanogo I, Subran L, Bloem MW. High food prices and the global financial crisis have reduced access to nutritious food and worsened nutritional status and health. J Nutr 2010; 140: 153S-61S.
150. Sztam KA, Fawzi WW, Duggan C. Macronutrient supplementation and food prices in HIV treatment. J Nutr 2010; 140: 213-23.
151. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva: WHO, 2006.